Table 2.
Baseline Patient Response to Conservative Therapy (PDE5-i and intracavernous alprostadil)
| No response to PDE5-I | 47 (94) |
| Severe side effects of PDE5-I | 3 (60) |
| No response to alprostadil | 45 (90) |
Values are n (%)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.